ArticleJournal for immunotherapy of cancer2020

Chimeric Ad5.F35 vector evades anti-adenovirus serotype 5 neutralization opposing GUCY2C-targeted antitumor immunity.

John C Flickinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.